Bullish indication on daily chart
In the last 4 years, only 1.26 % trading sessions saw intraday declines higher than 5 % .
Potential
Upside
1 Year
Target
BUY
Mean Recos by
20 Analysts
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
In the last 4 years, only 1.26 % trading sessions saw intraday declines higher than 5 % .
Company's annual revenue growth of 28.65% outperformed its 3 year CAGR of 20.73%. (Source: Consolidated Financials)
Daily MACD crossover appeared yesterday. Average price gain of 5.93% within 10 days of this signal in last 10 years.
Company has spent 2.35% of its operating revenues towards interest expenses and 16.7% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Max Healthcare Institute Ltd. share price moved down by -1.02% from its previous close of Rs 1,194.60. Max Healthcare Institute Ltd. stock last traded price is 1,182.50
Share Price | Value |
---|---|
Today/Current/Last | 1,182.50 |
Previous Day | 1,194.60 |
PE Ratio (x) | 102.77 | ||||||||||
EPS - TTM (₹) | 11.07 | ||||||||||
MCap (₹ Cr.) | 1,10,567 | ||||||||||
Sectoral MCap Rank | 1 | ||||||||||
PB Ratio (x) | 11.79 | ||||||||||
Div Yield (%) | 0.13 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 1,184.82 | ||||||||||
52W H/L (₹) |
1 Day | -1.02% |
1 Week | 3.83% |
1 Month | 4.86% |
3 Months | 22.63% |
1 Year | 45.67% |
3 Years | 230.91% |
5 Years | N.A. |
Current
Mean Recos by 20 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 |
Buy | 7 | 7 | 7 | 7 |
Hold | 3 | 3 | 3 | 3 |
Sell | 4 | 4 | 4 | 4 |
Strong Sell | - | - | - | - |
# Analysts | 20 | 20 | 20 | 20 |
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 28.65% outperformed its 3 year CAGR of 20.73%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 2.35% of its operating revenues towards interest expenses and 16.7% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|---|
Total Income | 1,956.66 | 1,901.61 | 1,748.30 | 1,577.63 | 1,468.15 |
Total Income Growth (%) | 2.89 | 8.77 | 10.82 | 7.46 | 6.31 |
Total Expenses | 1,498.95 | 1,540.35 | 1,341.07 | 1,232.44 | 1,111.69 |
Total Expenses Growth (%) | -2.69 | 14.86 | 8.81 | 10.86 | 10.06 |
EBIT | 457.71 | 361.26 | 407.23 | 345.19 | 356.46 |
EBIT Growth (%) | 26.70 | -11.29 | 17.97 | -3.16 | -3.90 |
Profit after Tax (PAT) | 319.00 | 238.80 | 281.81 | 236.27 | 251.54 |
PAT Growth (%) | 33.58 | -15.26 | 19.27 | -6.07 | -13.06 |
EBIT Margin (%) | 23.39 | 19.00 | 23.29 | 21.88 | 24.28 |
Net Profit Margin (%) | 16.30 | 12.56 | 16.12 | 14.98 | 17.13 |
Basic EPS (₹) | 3.28 | 2.46 | 2.90 | 2.43 | 2.59 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Total Assets | 15,214.48 | 11,999.94 | 10,101.85 | 9,189.13 | 8,544.44 |
Total Assets Growth (%) | 26.79 | 18.79 | 9.93 | 7.55 | 115.03 |
Total Liabilities | 5,833.61 | 3,591.80 | 2,692.26 | 2,906.66 | 2,905.76 |
Total Liabilities Growth (%) | 62.41 | 33.41 | -7.38 | 0.03 | 104.56 |
Total Equity | 9,380.87 | 8,408.14 | 7,409.59 | 6,282.47 | 5,638.68 |
Total Equity Growth (%) | 11.57 | 13.48 | 17.94 | 11.42 | 120.85 |
Current Ratio (x) | 0.88 | 1.37 | 1.86 | 1.32 | 1.45 |
Total Debt to Equity (x) | 0.32 | 0.14 | 0.08 | 0.12 | 0.16 |
Contingent Liabilities | 0.00 | 1,169.76 | 326.66 | 515.17 | 388.01 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 1631.74 cr for investing activities which is an YoY increase of 26.94%. (Source: Consolidated Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 1,459.65 | 1,121.80 | 1,209.18 | 748.49 | 117.86 |
Net Cash used in Investing Activities | -1,631.74 | -1,285.45 | -1,187.01 | -771.77 | -73.00 |
Net Cash flow from Financing Activities | -163.80 | -263.74 | -288.56 | -294.17 | 191.33 |
Net Cash Flow | -335.77 | -394.49 | -266.39 | -317.45 | 515.58 |
Closing Cash & Cash Equivalent | 661.58 | 979.84 | 42.75 | 309.14 | 626.59 |
Closing Cash & Cash Equivalent Growth (%) | -32.48 | 2,192.02 | -86.17 | -50.66 | 464.44 |
Total Debt/ CFO (x) | 2.06 | 1.02 | 0.47 | 0.97 | 7.61 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Return on Equity (%) | 11.46 | 12.57 | 14.89 | 9.63 | -2.43 |
Return on Capital Employed (%) | 12.27 | 13.25 | 12.67 | 10.06 | 4.43 |
Return on Assets (%) | 7.07 | 8.81 | 10.92 | 6.58 | -1.60 |
Interest Coverage Ratio (x) | 12.15 | 27.89 | 16.45 | 10.61 | 1.92 |
Asset Turnover Ratio (x) | 0.52 | 0.49 | 0.22 | 0.22 | 29.31 |
Price to Earnings (x) | 100.00 | 75.76 | 38.91 | 55.87 | -144.93 |
Price to Book (x) | 11.37 | 9.48 | 5.78 | 5.35 | 3.53 |
EV/EBITDA (x) | 54.35 | 47.77 | 30.38 | 31.65 | 38.85 |
EBITDA Margin (%) | 28.51 | 30.89 | 30.24 | 27.21 | 20.70 |
Bullish / Bearish signals for Max Healthcare basis selected technical indicators and moving average crossovers.
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
1190.08
LTP
1182.50
Choose from Peers
Choose from Stocks
MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
May 20, 2025 | May 13, 2025 | Board Meeting | Audited Results & Final Dividend |
Jan 30, 2025 | Jan 24, 2025 | Board Meeting | Quarterly Results |
Nov 05, 2024 | Oct 30, 2024 | Board Meeting | Quarterly Results |
Sep 20, 2024 | Aug 12, 2024 | AGM | - |
Aug 01, 2024 | Jul 24, 2024 | Board Meeting | Quarterly Results |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Final | 15% | 1.5 | Aug 23, 2024 | May 22, 2024 |
Final | 10% | 1.0 | Sep 08, 2023 | May 16, 2023 |
Final | 15% | 1.5 | - | May 20, 2025 |
No other corporate actions details are available.
Max Healthcare Institute Ltd., incorporated in the year 2001, is a Small Cap company (having a market cap of Rs 1,10,567.12 Crore) operating in Hospitals & Allied Services sector. Max Healthcare Institute Ltd. key Products/Revenue Segments include HealthCare Services, Other Operating Revenue and Drugs & Pharmaceuticals for the year ending 31-Mar-2024. Show More
Abhay Soi
Chairman & Managing DirectorAnil Kumar Bhatnagar
Non Executive DirectorNarayan K Seshadri
Non Executive DirectorAmrita Gangotra
Independent Woman DirectorIndustry
Key Indices Listed on
Nifty Midcap 50, Nifty Midcap 100, Nifty 200, + 36 more
Address
401, 4th Floor,Man Excellenza,S. V. Road,Mumbai, Maharashtra - 400056
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.